The Cytochemistry and Morphology Core facilIty comprises three units: a Light Microscopy Unit, an Electron Microscopy Unit, and an image Analysis Unit. This Core Facility is designed to provide accessible, state-of-the art microscopy for funded investigators. A range of services and techniques are provided including routine light photomicroscopy utilizing inverted microscopes or a Zeiss Photoscope III with phase contrast, differential interference contrast, epifluorescence, or interference reflection optics, high resolution immunocytochemistry of 5, 0.5, and 0.1 micromoles frozen sections, either double or single labeled, conventional electron microscopy of plastic sections, In situ hybridization, including labeling of sections with antibodies against protein moieties, scanning confocal microscopy, and image analysis of cells, tissue sections, or photographic negatives using a Zeiss IBAS image analyzer. Drs. Susette Mueller and Wen-Tien Chen are co-directors, and together with the microscopist, Dr. Maozheng Dai, have provided state-of-the-art microscopy instrumentation and expert assistance for studies in tumor cell biology. The instrumentation and personnel have been centralized over the last two years in the Preclinical Science Building. The use of the Core facility has expanded, with the light and image analysis units becoming more heavily utilized. An additional 25% time/effort of the image analysis technician is requested to support an increasingly sophisticated utilization of the Image Analysis Unit. The proposed support for the Image Analysis Technician, Mr. Zitzmann, will allow an increase in powerful image analysis applications tailored for specific research needs. Members from seven programs of the CCSG application, and from nine departments have utilized the Cytochemistry and Morphology Core in the last two years, including work from 23 peer-reviewed funded projects.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Georgetown University
United States
Zip Code
Fu, Ying; Silverstein, Shana; McCutcheon, Justine N et al. (2018) An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice. Hepatology 67:159-170
Pohlmann, Paula R; Isaacs, Claudine (2018) Extended Adjuvant Endocrine Therapy for Postmenopausal Women: Treating Many to Benefit a Few. J Natl Cancer Inst 110:
Xiao, David; Zheng, Chaoyi; Jindal, Manila et al. (2018) Medicaid Expansion and Disparity Reduction in Surgical Cancer Care at High-Quality Hospitals. J Am Coll Surg 226:22-29
Stires, Hillary; Heckler, Mary M; Fu, Xiaoyong et al. (2018) Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities. Mol Cell Endocrinol 471:105-117
Zheng, Wenjie; Wu, Xiuhua; Goudarzi, Maryam et al. (2018) Metabolomic alterations associated with Beh├žet's disease. Arthritis Res Ther 20:214
Kozlik, Petr; Goldman, Radoslav; Sanda, Miloslav (2018) Hydrophilic interaction liquid chromatography in the separation of glycopeptides and their isomers. Anal Bioanal Chem 410:5001-5008
Bluethmann, Shirley M; Sciamanna, Christopher N; Winkels, Renate M et al. (2018) Healthy Living After Cancer Treatment: Considerations for Clinical and Community Practice. Am J Lifestyle Med 12:215-219
Getnet, Derese; Gautam, Aarti; Kumar, Raina et al. (2018) Poisoning with Soman, an Organophosphorus Nerve Agent, Alters Fecal Bacterial Biota and Urine Metabolites: a case for Novel Signatures for Asymptomatic Nerve Agent Exposure. Appl Environ Microbiol :
Aldeghaither, Dalal S; Zahavi, David J; Murray, Joseph C et al. (2018) A Mechanism of Resistance to Antibody-Targeted Immune Attack. Cancer Immunol Res :
Graves, Kristi D; Hall, Michael J; Tercyak, Kenneth P (2018) Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for translational behavioral medicine research, practice, and policy. Transl Behav Med 8:4-6

Showing the most recent 10 out of 1120 publications